Bluebird Bio Inc Revenue per Employee (BLUE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Bluebird Bio Inc   (NASDAQ: BLUE)
 

Bluebird Bio Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 108.43% in the first quarter 2025, year on year to cumulative value of $104 million, Bluebird Bio Inc 's revenue per employee grew on a trailing twelve months basis to $ 419,137. The productivity of Bluebird Bio Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 220 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1574, from total ranking in previous quarter at 2404. Bluebird Bio Inc has 248 employees.


What is Sales per Employee Ratio?







BLUE Revenue per Employee (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Revenue Change 108.43 % 391.72 % -14.36 % 133.69 % 680.05 %
Sales per Employee (TTM) $ 419,137 337,931 214,194 221,371 184,230
BLUE's Total Ranking # 1574 # 2404 # 2966 # 0 # 0
Seq. Revenue Change 0.5 % 262.99 % -34.09 % -13.31 % 137.08 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 221
Overall Market # 1574

Revenue per Employee Statistics
High Average Low
$ 1,011,024 $ 205,914 $ -130,411
(Dec 31 2020)   (Sep 30 2022)



Financial Statements
Bluebird Bio Inc 's Revenue MRQ $ 39 Millions Visit BLUE's Income Statement
Bluebird Bio Inc 's Revenues TTM $ 104 Millions Visit BLUE's aggregate revenue growth
What are BLUE's Sales? Visit BLUE's Sales by Segment




Other Ratios
Bluebird Bio Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BLUE's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BLUE's Competitors
Revenue per Employee for BLUE's Suppliers
Revenue per Employee for BLUE's Customers

You may also want to know
BLUE's Sales Growth Rates BLUE's Pe Price to earnings ratio BLUE's Receivables Turnover Ratio BLUE's Stock Quote
BLUE's Net Income Growth Rates BLUE's Ps Price to Sales ratio BLUE's Sales per Employee BLUE's Asset Turnover Ratio
BLUE's Net Margin BLUE's Pb Price to Book ratio BLUE's Financial Strength Ratios BLUE's Dividend Payout Ratio
Date modified: 2026-08-29T17:19:42+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2025Number of Employees Mar 31 2025
Hims and Hers Health Inc   730,437.76 $ 1,783.729  Million 2,442 
Adaptimmune Therapeutics Plc  730,239.84 $ 179.639  Million 246 
Vaxart Inc   729,153.85 $ 47.395  Million 65 
Theravance Biopharma inc   725,177.78 $ 65.266  Million 90 
Sunshine Biopharma Inc   724,691.56 $ 36.235  Million 50 
Dyadic International Inc   710,868.80 $ 3.554  Million
Adma Biologics Inc   707,508.50 $ 457.758  Million 647 
Alphatec Holdings Inc   703,074.48 $ 641.907  Million 913 
X4 Pharmaceuticals Inc  696,977.78 $ 31.364  Million 45 
Ani Pharmaceuticals Inc  694,915.46 $ 674.068  Million 970 
Allurion Technologies Inc   678,000.00 $ 27.798  Million 41 
Moderna Inc   675,957.45 $ 3,177.000  Million 4,700 
Zevra Therapeutics Inc   665,377.05 $ 40.588  Million 61 
Sanuwave Health Inc   658,000.00 $ 36.190  Million 55 
Biofrontera Inc   647,815.22 $ 59.599  Million 92 
Zoetis Inc   640,413.79 $ 9,286.000  Million 14,500 
Cerus Corporation  637,756.94 $ 183.674  Million 288 
Immunocore Holdings Plc  636,604.96 $ 333.581  Million 524 
Sensus Healthcare Inc   635,366.67 $ 38.122  Million 60 
Johnson and Johnson  634,453.13 $ 89,331.000  Million 140,800 
Tarsus Pharmaceuticals Inc   631,551.35 $ 233.674  Million 370 
Tvardi Therapeutics Inc   630,916.67 $ 7.571  Million 12 
Inspire Medical Systems inc   629,537.13 $ 839.173  Million 1,333 
Organon and Co   629,400.00 $ 6,294.000  Million 10,000 
The Oncology Institute Inc   628,942.28 $ 403.152  Million 641 
Option Care Health Inc   627,349.87 $ 5,185.674  Million 8,266 
Lifecore Biomedical Inc   624,818.18 $ 130.587  Million 209 
Karyopharm Therapeutics Inc   623,359.65 $ 142.126  Million 228 
Ensysce Biosciences Inc   622,408.10 $ 6.224  Million 10 
Takeda Pharmaceutical Company Limited  620,934.00 $ 29,183.898  Million 47,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.